justbacked

Biotechnology, Health Care, Life Science, Neuroscience, Therapeutics

BrainChild Bio

BrainChild Bio raised $116M in a Series A announced on Sep 8, 2026, led by WRF Capital, Seattle Children’s, ScaleReady. Since then it has posted 5 roles (4 still open), the first 28 days after it. Another 1 open role was posted before the announcement. With 5 open roles it is hiring more than 20% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $116M over 1 round from 1 investors.

Roles posted per month since the round
  • October 20264
  • November 20261

From BrainChild Bio's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

Why join BrainChild Bio?

Families facing brain tumors have few options, and a therapy that works inside the central nervous system could change that for children first, then adults. BrainChild Bio, a Seattle biotechnology company, is backed by a $116M Series A that outsizes 93% of rounds at its stage, with Seattle Children's in the syndicate. Four open roles in legal, hardware and operations say the build-out has started.

JustBacked's take, based on BrainChild Bio's own site and its funding and hiring data.

Series A · $116M · 74d agobrainchildbio.com

Hiring velocity

Open roles
5
Added, 30 days
+1
Added, 7 days
+0
Closed, 30 days
3
Raised
74 days ago
Led by
WRF Capital, Seattle Children’s, ScaleReady
Team size
11-50
HQ
Seattle, Washington, United States
Newest role
16d ago
Tracked since
Oct 4, 2026

Where they're hiring

Science2
Finance1
Hardware1
Operations1

Open roles at BrainChild Bio

Source: brainchildbio.com, checked daily.